Terms: = Skin cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Treatment
10 results:
1. Quercetin increases mitochondrial proteins (VDAC and SDH) and downmodulates AXL and pim-1 tyrosine kinase receptors in NRAS melanoma cells.
Rocha-Brito KJP; Clerici SP; Cordeiro HG; Scotá Ferreira AP; Barreto Fonseca EM; Gonçalves PR; Abrantes JLF; Milani R; Massaro RR; Maria-Engler SS; Ferreira-Halder CV
Biol Chem; 2022 Feb; 403(3):293-303. PubMed ID: 34854272
[TBL] [Abstract] [Full Text] [Related]
2. Designer broad-spectrum polyimidazolium antibiotics.
Zhong W; Shi Z; Mahadevegowda SH; Liu B; Zhang K; Koh CH; Ruan L; Chen Y; Zeden MS; Pee CJE; Marimuthu K; De PP; Ng OT; Zhu Y; Chi YR; Hammond PT; Yang L; Gan YH; Pethe K; Greenberg EP; Gründling A; Chan-Park MB
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31376-31385. PubMed ID: 33229526
[TBL] [Abstract] [Full Text] [Related]
3. Post-irradiation morphoea of the breast: a case report and review of the literature.
Gonzalez-Ericsson PI; Estrada MV; Al-Rohil R; Sanders ME
Histopathology; 2018 Jan; 72(2):342-350. PubMed ID: 29110314
[TBL] [Abstract] [Full Text] [Related]
4. [Primary intramedullary melanoma: Case report and literature review].
Narváez-Martínez Y; de la Ossa N; López-Martos R; Cohn-Reinoso C; Castellví-Juan M; Martin-Ferrer S
Neurocirugia (Astur); 2017; 28(4):190-196. PubMed ID: 28237771
[TBL] [Abstract] [Full Text] [Related]
5. pim kinases as therapeutic targets against advanced melanoma.
Shannan B; Watters A; Chen Q; Mollin S; Dörr M; Meggers E; Xu X; Gimotty PA; Perego M; Li L; Benci J; Krepler C; Brafford P; Zhang J; Wei Z; Zhang G; Liu Q; Yin X; Nathanson KL; Herlyn M; Vultur A
Oncotarget; 2016 Aug; 7(34):54897-54912. PubMed ID: 27448973
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract] [Full Text] [Related]
7. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.
Wozniak MB; Villuendas R; Bischoff JR; Aparicio CB; Martínez Leal JF; de La Cueva P; Rodriguez ME; Herreros B; Martin-Perez D; Longo MI; Herrera M; Piris MA; Ortiz-Romero PL
Haematologica; 2010 Apr; 95(4):613-21. PubMed ID: 20133897
[TBL] [Abstract] [Full Text] [Related]
8. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract] [Full Text] [Related]
9. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract] [Full Text] [Related]
10. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
Hoefnagel JJ; Dijkman R; Basso K; Jansen PM; Hallermann C; Willemze R; Tensen CP; Vermeer MH
Blood; 2005 May; 105(9):3671-8. PubMed ID: 15308563
[TBL] [Abstract] [Full Text] [Related]
